Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Anti-viral veto cell therapy - Cell Source

Next Previous
Drug Profile

Anti-viral veto cell therapy - Cell Source

Alternative Names: T-central memory Veto Cell - Cell Source; TCM Veto Cell - Cell Source; Veto Cell - Cell Source

Latest Information Update: 28 Apr 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Weizmann Institute of Science
  • Developer Cell Source
  • Class Cell therapies
  • Mechanism of Action Cell replacements; Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Graft-versus-host disease; Viral infections
  • No development reported Sickle cell anaemia; Transplant rejection

Most Recent Events

  • 28 Apr 2025 No recent reports of development identified for preclinical development in Sickle-cell-anaemia in Israel (IV)
  • 27 Dec 2024 Pharmacodynamics data from a preclinical trial in Graft-versus-host disease released by Cell Source
  • 19 Mar 2021 Cell Source receives issuance notices for two patents from the USPTO for Veto Cell technology in USA

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top